Recently, Genertec Meheco, The United Laboratories, and PT Etana Biotechnologies Indonesia reached a significant strategic cooperation. The three parties will jointly advance the localized manufacturing and marketing of insulin and GLP-1 products in Indonesia.

This cooperation marks the first time China's full range of insulin products will be introduced into the Indonesian market, representing a milestone for the global development of Chinese biologics.

Prior to the signing of the agreement, the three parties had conducted in-depth negotiations and on-site inspections regarding key areas such as technology, market, and registration, laying a solid foundation for the successful implementation of this partnership. This initiative also establishes a new benchmark for Chinese pharmaceutical companies seeking to expand into international markets.